All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond. The BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs:
- 27 new BP monographs,
- 17 new Ph. Eur. monographs;
- 93 amended BP monographs;
- all monographs from the Ph. Eur. 11th edition; Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.
New for the BP 2024
The BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
Updated features for the 2024 edition include:
- A fresh and user-friendly site design, coupled with improved navigation
- Enhanced purchasing journeys for a seamless experience
- Enhanced layout allows you to search and find the monographs you need
- Advanced in-publication search functionality
- A revamped timeline and tracked changes feature, enabling you to track the evolution of monographs over time.
British Pharmacopoeia 2024 PDF Free Download
The British Pharmacopoeia 2024 replaces the previous edition, compiled by the British Pharmacopoeia Commission with the assistance of its Expert Advisory Groups, Panels of Experts, and Working Parties. This comprehensive volume includes approximately 4,000 monographs for substances, preparations, and articles used in medical practice.
Volume Breakdown
Volumes I and II:
Medicinal Substances
Volume III:
Formulated Preparations: General Monographs and Specific Monographs
Volume IV:
Herbal Drugs
Herbal Drug Preparations and Herbal Medicinal Products
Materials for Homoeopathic Preparations
Blood-related Products
Immunological Products
Radiopharmaceutical Preparations
Surgical Materials
Volume V:
Infrared Reference Spectra, Appendices, Supplementary Chapters, Index
Volume VI:
British Pharmacopoeia (Veterinary) 2024
Many monographs originate nationally and have been developed or revised under the British Pharmacopoeia Commission. Others, indicated by a chaplet of stars, are developed or revised by the European Pharmacopoeia Commission and are reproduced from the European Pharmacopoeia. This edition, along with the British Pharmacopoeia (Veterinary) 2024, includes all monographs from the 10th Edition of the European Pharmacopoeia, as updated by Supplements 10.1 to 10.8. This provides users with a comprehensive index of all current UK Pharmacopoeial standards for human medicines.
When an appendix method, test, or other matter is referenced in a monograph reproduced from the European Pharmacopoeia, Part III of the General Notices applies. For other monographs, Part II of General Notices applies.
British Pharmacopoeia (Veterinary) 2024
Prepared under regulation 317(3)(b) of the Human Medicines Regulations 2012 and published in accordance with regulation 317(4), this edition includes monographs from the 10th Edition of the European Pharmacopoeia, updated by Supplements 10.1 to 10.8, and is incorporated into both the British Pharmacopoeia (Veterinary) and the associated edition of the British Pharmacopoeia.
Supplementary Chapters
These chapters do not contain any mandatory standards, tests, or assays for any Pharmacopoeial article. Instead, they offer explanatory and ancillary texts for the assistance and information of Pharmacopoeia users.
Tags
Pharmacopoeia
